Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Ipca Laboratories Ltd

NSE: IPCALAB

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Ipca Laboratories Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 49,556.04 Cr.
Price in snapshot: ₹ 1,953.3
ROE: 15.78 %
ROCE: 18.3 %
Dividend Yield: 0 %

Snapshot updated 22 July 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q1 FY27, dated 17 August 2026.
Annual-report coverage: FY2026.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings